US Stock MarketDetailed Quotes

FBRX Forte Biosciences

Watchlist
  • 17.100
  • +1.020+6.34%
Trading Nov 26 15:45 ET
25.00MMarket Cap-1043P/E (TTM)

Forte Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
10.21%-8.13M
-8.42%-5.94M
-28.11%-6.67M
-250.71%-28.71M
-210.02%-8.97M
-366.91%-9.06M
-297.60%-5.48M
-163.49%-5.2M
50.92%-8.19M
19.24%-2.89M
Net income from continuing operations
15.70%-8.39M
-40.64%-12.51M
-9.88%-7.42M
-126.79%-31.48M
-20.40%-5.87M
-192.79%-9.96M
-193.11%-8.9M
-163.07%-6.75M
36.07%-13.88M
-45.97%-4.88M
Depreciation and amortization
233.33%10K
--10K
--9K
--9K
--6K
--3K
--0
--0
--0
--0
Other non cash items
----
----
----
---131K
----
----
----
----
----
----
Change In working capital
-329.58%-551K
122.96%5.77M
-108.18%-55K
-123.35%-392K
-446.17%-3.89M
-56.68%240K
457.54%2.59M
245.14%672K
133.19%1.68M
176.00%1.12M
-Change in prepaid assets
98.50%-13K
-122.08%-17K
206.59%279K
-429.07%-849K
-182.42%-150K
-335.68%-867K
-67.37%77K
133.33%91K
-78.87%258K
-63.82%182K
-Change in payables and accrued expense
-148.60%-538K
130.48%5.79M
-157.49%-334K
-67.84%457K
-497.13%-3.74M
47.01%1.11M
1,000.88%2.51M
215.74%581K
383.63%1.42M
147.53%942K
Cash from discontinued investing activities
Operating cash flow
10.21%-8.13M
-8.42%-5.94M
-28.11%-6.67M
-250.71%-28.71M
-210.02%-8.97M
-366.91%-9.06M
-297.60%-5.48M
-163.49%-5.2M
50.92%-8.19M
19.24%-2.89M
Investing cash flow
Cash flow from continuing investing activities
0
0
-6K
47K
-16K
10.03M
-9.97M
0
0
0
Net PPE purchase and sale
--0
--0
---6K
---88K
---17K
---71K
--0
--0
--0
--0
Net investment purchase and sale
--0
----
----
--135K
--1K
--10.1M
----
----
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
---6K
--47K
---16K
--10.03M
---9.97M
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-100.01%-2K
58.33%-10K
-233.33%-8K
240.89%24.68M
-36.36%-75K
233.02%24.78M
78.18%-24K
117.65%6K
16,556.82%7.24M
-41.03%-55K
Net common stock issuance
----
----
----
242.07%24.73M
-16.36%-64K
----
----
----
--7.23M
---55K
Proceeds from stock option exercised by employees
-33.33%6K
--0
33.33%8K
33.33%16K
--1K
--9K
--0
-50.00%6K
-80.65%12K
--0
Net other financing activities
70.83%-7K
---10K
---16K
---60K
---12K
---24K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-100.01%-2K
58.33%-10K
-233.33%-8K
240.89%24.68M
-36.36%-75K
233.02%24.78M
78.18%-24K
117.65%6K
16,556.82%7.24M
-41.03%-55K
Net cash flow
Beginning cash position
19.86%24.5M
-15.20%30.44M
-9.67%37.13M
-2.25%41.1M
4.85%46.19M
-46.98%20.44M
-10.32%35.9M
-2.25%41.1M
-28.45%42.04M
-3.54%44.05M
Current changes in cash
-131.60%-8.14M
61.55%-5.95M
-28.53%-6.68M
-321.08%-3.98M
-207.33%-9.06M
368.13%25.75M
-939.95%-15.46M
-158.74%-5.2M
94.35%-944K
18.59%-2.95M
End cash Position
-64.57%16.36M
19.86%24.5M
-15.20%30.44M
-9.67%37.13M
-9.67%37.13M
4.85%46.19M
-46.98%20.44M
-10.32%35.9M
-2.25%41.1M
-2.25%41.1M
Free cash flow
10.91%-8.13M
-8.42%-5.94M
-28.23%-6.67M
-251.79%-28.79M
-210.61%-8.99M
-370.57%-9.13M
-297.60%-5.48M
-163.49%-5.2M
50.92%-8.19M
19.24%-2.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 10.21%-8.13M-8.42%-5.94M-28.11%-6.67M-250.71%-28.71M-210.02%-8.97M-366.91%-9.06M-297.60%-5.48M-163.49%-5.2M50.92%-8.19M19.24%-2.89M
Net income from continuing operations 15.70%-8.39M-40.64%-12.51M-9.88%-7.42M-126.79%-31.48M-20.40%-5.87M-192.79%-9.96M-193.11%-8.9M-163.07%-6.75M36.07%-13.88M-45.97%-4.88M
Depreciation and amortization 233.33%10K--10K--9K--9K--6K--3K--0--0--0--0
Other non cash items ---------------131K------------------------
Change In working capital -329.58%-551K122.96%5.77M-108.18%-55K-123.35%-392K-446.17%-3.89M-56.68%240K457.54%2.59M245.14%672K133.19%1.68M176.00%1.12M
-Change in prepaid assets 98.50%-13K-122.08%-17K206.59%279K-429.07%-849K-182.42%-150K-335.68%-867K-67.37%77K133.33%91K-78.87%258K-63.82%182K
-Change in payables and accrued expense -148.60%-538K130.48%5.79M-157.49%-334K-67.84%457K-497.13%-3.74M47.01%1.11M1,000.88%2.51M215.74%581K383.63%1.42M147.53%942K
Cash from discontinued investing activities
Operating cash flow 10.21%-8.13M-8.42%-5.94M-28.11%-6.67M-250.71%-28.71M-210.02%-8.97M-366.91%-9.06M-297.60%-5.48M-163.49%-5.2M50.92%-8.19M19.24%-2.89M
Investing cash flow
Cash flow from continuing investing activities 00-6K47K-16K10.03M-9.97M000
Net PPE purchase and sale --0--0---6K---88K---17K---71K--0--0--0--0
Net investment purchase and sale --0----------135K--1K--10.1M----------0--0
Cash from discontinued investing activities
Investing cash flow --0--0---6K--47K---16K--10.03M---9.97M--0--0--0
Financing cash flow
Cash flow from continuing financing activities -100.01%-2K58.33%-10K-233.33%-8K240.89%24.68M-36.36%-75K233.02%24.78M78.18%-24K117.65%6K16,556.82%7.24M-41.03%-55K
Net common stock issuance ------------242.07%24.73M-16.36%-64K--------------7.23M---55K
Proceeds from stock option exercised by employees -33.33%6K--033.33%8K33.33%16K--1K--9K--0-50.00%6K-80.65%12K--0
Net other financing activities 70.83%-7K---10K---16K---60K---12K---24K----------------
Cash from discontinued financing activities
Financing cash flow -100.01%-2K58.33%-10K-233.33%-8K240.89%24.68M-36.36%-75K233.02%24.78M78.18%-24K117.65%6K16,556.82%7.24M-41.03%-55K
Net cash flow
Beginning cash position 19.86%24.5M-15.20%30.44M-9.67%37.13M-2.25%41.1M4.85%46.19M-46.98%20.44M-10.32%35.9M-2.25%41.1M-28.45%42.04M-3.54%44.05M
Current changes in cash -131.60%-8.14M61.55%-5.95M-28.53%-6.68M-321.08%-3.98M-207.33%-9.06M368.13%25.75M-939.95%-15.46M-158.74%-5.2M94.35%-944K18.59%-2.95M
End cash Position -64.57%16.36M19.86%24.5M-15.20%30.44M-9.67%37.13M-9.67%37.13M4.85%46.19M-46.98%20.44M-10.32%35.9M-2.25%41.1M-2.25%41.1M
Free cash flow 10.91%-8.13M-8.42%-5.94M-28.23%-6.67M-251.79%-28.79M-210.61%-8.99M-370.57%-9.13M-297.60%-5.48M-163.49%-5.2M50.92%-8.19M19.24%-2.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data